X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (55726) 55726
Book Review (6609) 6609
Publication (3601) 3601
Newsletter (179) 179
Book Chapter (133) 133
Conference Proceeding (124) 124
Magazine Article (77) 77
Book / eBook (68) 68
Dissertation (42) 42
Newspaper Article (28) 28
Government Document (8) 8
Data Set (4) 4
Reference (4) 4
Web Resource (3) 3
Streaming Video (2) 2
Paper (1) 1
Presentation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (51679) 51679
index medicus (51024) 51024
female (48953) 48953
ovarian neoplasms - pathology (30896) 30896
oncology (21253) 21253
middle aged (20346) 20346
adult (18691) 18691
ovarian cancer (16230) 16230
aged (14800) 14800
cancer (13095) 13095
obstetrics & gynecology (9287) 9287
prognosis (8557) 8557
animals (8299) 8299
neoplasm staging (8145) 8145
ovarian neoplasms - genetics (8016) 8016
carcinoma (7519) 7519
ovarian neoplasms - drug therapy (7398) 7398
cell line, tumor (7379) 7379
ovarian neoplasms - metabolism (7162) 7162
ovarian-cancer (7052) 7052
tumors (7032) 7032
ovarian neoplasms - surgery (6866) 6866
pathology (6337) 6337
chemotherapy (6201) 6201
male (6106) 6106
expression (6101) 6101
immunohistochemistry (5860) 5860
mice (5465) 5465
aged, 80 and over (5221) 5221
ovarian neoplasms - diagnosis (5170) 5170
research (4729) 4729
metastasis (4690) 4690
retrospective studies (4323) 4323
abridged index medicus (4205) 4205
adolescent (4149) 4149
survival (4089) 4089
surgery (4035) 4035
breast-cancer (4029) 4029
analysis (3992) 3992
breast cancer (3867) 3867
apoptosis (3693) 3693
ovarian neoplasms - mortality (3629) 3629
care and treatment (3549) 3549
treatment outcome (3483) 3483
gene expression regulation, neoplastic (3434) 3434
health aspects (3412) 3412
diagnosis (3287) 3287
ovarian neoplasms - therapy (3273) 3273
genetic aspects (3270) 3270
cell biology (3241) 3241
gene expression (3173) 3173
risk factors (3123) 3123
mutation (3071) 3071
antineoplastic combined chemotherapy protocols - therapeutic use (3069) 3069
breast neoplasms - pathology (3021) 3021
diagnosis, differential (2989) 2989
tumor cells, cultured (2866) 2866
proteins (2848) 2848
ovary (2704) 2704
article (2674) 2674
survival rate (2641) 2641
ovary - pathology (2639) 2639
women (2605) 2605
medicine & public health (2594) 2594
ovarian carcinoma (2492) 2492
adenocarcinoma - pathology (2484) 2484
young adult (2480) 2480
follow-up studies (2425) 2425
breast neoplasms - genetics (2401) 2401
development and progression (2385) 2385
antineoplastic agents - pharmacology (2375) 2375
cisplatin (2362) 2362
survival analysis (2346) 2346
carcinoma - pathology (2337) 2337
neoplasms, glandular and epithelial - pathology (2337) 2337
obstetrics and gynecology (2334) 2334
biochemistry & molecular biology (2307) 2307
carcinoma, ovarian epithelial (2304) 2304
mice, nude (2280) 2280
neoplasm metastasis (2279) 2279
cells (2278) 2278
medicine (2277) 2277
hematology, oncology and palliative medicine (2248) 2248
research article (2209) 2209
cell proliferation (2198) 2198
disease-free survival (2154) 2154
neoplasm invasiveness (2064) 2064
antineoplastic agents - therapeutic use (2031) 2031
combined modality therapy (2025) 2025
apoptosis - drug effects (1972) 1972
ovarian neoplasms - complications (1967) 1967
ovarian neoplasms (1962) 1962
pregnancy (1949) 1949
biomarkers, tumor - metabolism (1929) 1929
risk (1927) 1927
time factors (1857) 1857
child (1855) 1855
cystadenocarcinoma, serous - pathology (1826) 1826
signal transduction (1816) 1816
medical prognosis (1727) 1727
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (45) 45
Online Resources - Online (6) 6
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Lakeridge Health Sciences - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (50862) 50862
Chinese (997) 997
German (899) 899
French (869) 869
Japanese (692) 692
Russian (449) 449
Italian (358) 358
Spanish (283) 283
Polish (257) 257
Bulgarian (126) 126
Czech (84) 84
Hungarian (61) 61
Portuguese (41) 41
Croatian (37) 37
Danish (36) 36
Dutch (34) 34
Romanian (23) 23
Hebrew (20) 20
Norwegian (20) 20
Korean (19) 19
Serbian (19) 19
Ukrainian (18) 18
Turkish (17) 17
Swedish (16) 16
Finnish (6) 6
Slovak (5) 5
Lithuanian (1) 1
Persian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 18, Issue 1, pp. 75 - 87
Summary Background Poly(ADP-ribose) polymerase (PARP) inhibitors have activity in ovarian carcinomas with homologous recombination deficiency. Along with BRCA1... 
Hematology, Oncology and Palliative Medicine | BRCA MUTATION | POLY(ADP-RIBOSE) POLYMERASE | RANDOMIZED PHASE-2 | ONCOLOGY | HOMOLOGOUS RECOMBINATION DEFICIENCY | MUTANT-CELLS | PROSTATE-CANCER | INHIBITORS | DNA-REPAIR | NEGATIVE BREAST-CANCER | GENOMIC LOSS | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Salvage Therapy | Neoplasm Recurrence, Local - drug therapy | Germ-Line Mutation - genetics | Neoplasm Recurrence, Local - pathology | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Peritoneal Neoplasms - drug therapy | Fallopian Tube Neoplasms - genetics | Female | Antineoplastic Agents - pharmacology | Poly(ADP-ribose) Polymerases - chemistry | Ovarian Neoplasms - drug therapy | Platinum - pharmacology | Fallopian Tube Neoplasms - drug therapy | Peritoneal Neoplasms - pathology | Neoplasms, Glandular and Epithelial - pathology | Fallopian Tube Neoplasms - pathology | Survival Rate | Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use | BRCA1 Protein - genetics | International Agencies | Peritoneal Neoplasms - genetics | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Indoles - therapeutic use | Neoplasm Recurrence, Local - genetics | Aged | Neoplasm Staging | BRCA2 Protein - genetics | Drug Resistance, Neoplasm - drug effects | Sugars | Monosaccharides | Ovarian cancer | Analysis | Carcinoma | Cancer | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 2013, Volume 497, Issue 7447, pp. 108 - 112
Cancers acquire resistance to systemic treatment as a result of clonal evolution and selection(1,2). Repeat biopsies to study genomic evolution as a result of... 
HETEROGENEITY | LUNG-CANCER | ACTIVATION | EVOLUTION | VARIANTS | AXL | MULTIDISCIPLINARY SCIENCES | TAMOXIFEN RESISTANCE | TUMOR-CELLS | MUTATIONS | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Genomics | Humans | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Ovarian Neoplasms - genetics | Neoplasms - genetics | DNA Mutational Analysis | Female | Antineoplastic Agents - pharmacology | DNA, Neoplasm - analysis | Ovarian Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Intercellular Signaling Peptides and Proteins - genetics | Breast Neoplasms - drug therapy | Genome, Human - genetics | Neoplasms - drug therapy | Phosphatidylinositol 3-Kinases - genetics | Drug Resistance, Neoplasm - genetics | Exome - genetics | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Breast Neoplasms - pathology | Retinoblastoma Protein - genetics | Plasma - chemistry | Alleles | Carcinoma, Non-Small-Cell Lung - drug therapy | DNA, Neoplasm - genetics | Neoplasms - pathology | Mediator Complex Subunit 1 - genetics | Drug Resistance, Neoplasm - drug effects | Evolution, Molecular | Antimitotic agents | Care and treatment | Physiological aspects | Dosage and administration | Genetic aspects | Research | Nucleotide sequencing | Drug resistance | Antineoplastic agents | DNA sequencing | Blood plasma | Cancer | Plasma | Biopsy | Breast cancer | Genomes | Mutation | Patients | Deoxyribonucleic acid--DNA | Tumors | Index Medicus
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 02/2007, Volume 31, Issue 2, pp. 161 - 169
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2015, Volume 33, Issue 34, pp. 4015 - 4022
Journal Article
Science, ISSN 0036-8075, 2/2011, Volume 331, Issue 6017, pp. 593 - 596
Satellite repeats in heterochromatin are transcribed into noncoding RNAs that have been linked to gene silencing and maintenance of chromosomal integrity.... 
Tumor cell line | Artificial satellites | RNA | Lungs | Genes | Liver | REPORTS | Cell lines | Pancreas | Tumors | Cancer | ELEMENTS | CELLS | SMALL RNAS | HUMAN GENOMES | PERVASIVE TRANSCRIPTION | MULTIDISCIPLINARY SCIENCES | MOUSE | DIFFERENTIATION | Colonic Neoplasms - genetics | RNA, Untranslated - metabolism | Humans | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Male | Gene Expression Profiling | RNA, Neoplasm - metabolism | RNA, Untranslated - genetics | Heterochromatin - chemistry | Carcinoma, Pancreatic Ductal - genetics | Ovarian Neoplasms - genetics | DNA Methylation | Carcinoma in Situ - genetics | Prostatic Neoplasms - genetics | Neoplasms - genetics | Neurosecretory Systems - metabolism | Female | Transcription, Genetic | Lung Neoplasms - genetics | Prostatic Neoplasms - pathology | Gene Expression | Carcinoma in Situ - pathology | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - genetics | Carcinoma, Pancreatic Ductal - pathology | Animals | Heterochromatin - genetics | Long Interspersed Nucleotide Elements | Mice, Nude | Colonic Neoplasms - pathology | RNA, Neoplasm - genetics | DNA, Satellite - genetics | Mice | DNA, Neoplasm - genetics | Neoplasms - pathology | Epithelial cells | Analysis | Microsatellites (Genetics) | Genetic aspects | Gene expression | Health aspects | Biomarkers | Chromatin | Pancreatic cancer | Deoxyribonucleic acid--DNA | Index Medicus | Human | Cellular | Satellites | Insertion | Aberration | Colon
Journal Article
Human Pathology, ISSN 0046-8177, 2013, Volume 44, Issue 11, pp. 2563 - 2570
Summary BRAF mutation is seen in a variety of human neoplasms including cutaneous malignant melanoma, papillary thyroid carcinoma, colorectal carcinoma,... 
Pathology | Immunohistochemistry | Anti–B-Raf | BRAF V600E | VE1 | Glioma | Melanoma | Thyroid carcinoma | Anti-B-Raf | PROTEIN | IMPROVED SURVIVAL | PATHOLOGY | CANCER | TUMORS | HAIRY-CELL LEUKEMIA | THERAPY | MEK INHIBITION | GENE | MUTANT BRAF | VEMURAFENIB | Neoplasms - metabolism | Gastrointestinal Neoplasms - genetics | Humans | Lung Neoplasms - metabolism | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Mutation, Missense | Breast Neoplasms - metabolism | Glioma - metabolism | Glioma - genetics | Ovarian Neoplasms - genetics | Gastrointestinal Neoplasms - pathology | Neoplasms - genetics | DNA Mutational Analysis | Melanoma - genetics | Glioma - pathology | Sensitivity and Specificity | Biomarkers, Tumor - metabolism | Female | Ovarian Neoplasms - metabolism | Carcinoma - pathology | Antibodies, Monoclonal - immunology | Proto-Oncogene Proteins B-raf - metabolism | Gastrointestinal Neoplasms - metabolism | Lung Neoplasms - genetics | Melanoma - metabolism | Mutant Proteins - genetics | Mutant Proteins - metabolism | Melanoma - pathology | Thyroid Neoplasms - genetics | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Proto-Oncogene Proteins B-raf - genetics | Carcinoma - genetics | Biomarkers, Tumor - genetics | Carcinoma - metabolism | Neoplasms - pathology | Amino Acid Substitution | Thyroid Neoplasms - metabolism | Thyroid Neoplasms - pathology | Carcinoma | Gene mutations | Gliomas | Thyroid diseases | Monoclonal antibodies | Genetic aspects | Comparative analysis | Lung cancer, Non-small cell | Cancer | Breast cancer | Mutation | Tumors | Skin cancer | Index Medicus
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2009, Volume 137, Issue 6, pp. 1976 - 1985.e10
Background & Aims MUTYH -associated polyposis (MAP) is characterized by a lifetime risk of colorectal cancer of up to 100%. However, no systematic evaluation... 
Gastroenterology and Hepatology | BASE-EXCISION-REPAIR | URINARY-TRACT CANCER | APC GENE MUTATION | MUIR-TORRE-SYNDROME | NONPOLYPOSIS COLORECTAL-CANCER | DUODENAL ADENOMATOSIS | FAMILIAL ADENOMATOUS POLYPOSIS | MYH-ASSOCIATED POLYPOSIS | LYNCH SYNDROME | GASTROENTEROLOGY & HEPATOLOGY | MSH2 MUTATION CARRIERS | Gastrointestinal Neoplasms - genetics | Humans | Middle Aged | Adenomatous Polyposis Coli - epidemiology | Ovarian Neoplasms - pathology | Male | Adenomatous Polyposis Coli - pathology | Incidence | Ovarian Neoplasms - genetics | Young Adult | Gastrointestinal Neoplasms - pathology | Gastrointestinal Neoplasms - epidemiology | Urinary Bladder Neoplasms - genetics | Urinary Bladder Neoplasms - pathology | Adult | Female | Retrospective Studies | Endoscopy | Adenomatous Polyposis Coli - genetics | Child | Urinary Bladder Neoplasms - epidemiology | Breast Neoplasms - epidemiology | Skin Neoplasms - pathology | Genetic Predisposition to Disease | Sebaceous Gland Neoplasms - epidemiology | Risk Assessment | Risk Factors | Sebaceous Gland Neoplasms - genetics | DNA Glycosylases - genetics | Kaplan-Meier Estimate | Europe - epidemiology | Skin Neoplasms - epidemiology | Ovarian Neoplasms - epidemiology | Phenotype | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Sebaceous Gland Neoplasms - pathology | Skin Neoplasms - genetics | Adolescent | Age of Onset | Aged | Medical colleges | Animal pigments | Genetic disorders | Oncology, Experimental | Colorectal cancer | Research | Cancer | Tumors | Medical informatics | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2010, Volume 28, Issue 15, pp. 2512 - 2519
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 01/2016, Volume 40, Issue 1, pp. 14 - 26
Journal Article